| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Trial |
Although most patients with obstructive airways disease show some amelioration with long-term inhaled corticosteroid therapy, the extent of improvement may vary considerably between patients. Patients with mild to moderately severe obstructive airways disease (asthma and COPD) were selected if provocative concentration producing a 20% fall in forced expiratory volume in one second (PC20) < or = 8 mg.ml-1, and forced expiratory volume in one second (FEV1) < 95% confidence intervals (CI) of predicted normal. The independent influences of baseline PC20FEV1, inspiratory vital capacity (IVC), bronchodilator response, smoking habits, and allergy both on the "immediate" (within 3 months) response in FEV1 and the change in long-term (from 3 months onwards) slope of FEV1 with inhaled corticosteroids were analysed. Patients had a larger "immediate" improvement in their FEV1 with inhaled corticosteroids with each doubling doses lower PC20, with each ten-fold higher immunoglobulin E (IgE), and if they did not smoke. Total IgE proved a better independent predictor of "immediate" response than specific IgE for house dust mite, skin tests, or blood eosinophils. A more favourable long-term slope of FEV1 was predicted by a larger baseline bronchodilator response, but not by smoking. In conclusion, PC20, total IgE, and smoking habits are independent predictors of immediate treatment response to inhaled corticosteroids. Bronchodilator response is the single independent predictor of changes in long-term slope of FEV1 with corticosteroid treatment.
This article has been cited by other articles:
|
|
 |
|
  N. J. Trimble, F. M. Botelho, C. M. T. Bauer, R. Fattouh, and M. R. Stampfli Adjuvant and Anti-Inflammatory Properties of Cigarette Smoke in Murine Allergic Airway Inflammation Am. J. Respir. Cell Mol. Biol., January 1, 2009; 40(1): 38 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bjermer Review: Evaluating combination therapies for asthma: pros, cons, and comparative benefits Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 149 - 161. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Bacci, S. Cianchetti, M. Bartoli, F. L. Dente, A. Di Franco, B. Vagaggini, and P. Paggiaro Low Sputum Eosinophils Predict the Lack of Response to Beclomethasone in Symptomatic Asthmatic Patients Chest, March 1, 2006; 129(3): 565 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Choo-Kang Becoming a Complete "Asthmologist" Chest, November 1, 2005; 128(5): 3093 - 3096. [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Robbins, M. A. Pouladi, R. Fattouh, D. E. Dawe, N. Vujicic, C. D. Richards, M. Jordana, M. D. Inman, and M. R. Stampfli Mainstream Cigarette Smoke Exposure Attenuates Airway Immune Inflammatory Responses to Surrogate and Common Environmental Allergens in Mice, Despite Evidence of Increased Systemic Sensitization J. Immunol., September 1, 2005; 175(5): 2834 - 2842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.C. Thomson, R. Chaudhuri, and E. Livingston Asthma and cigarette smoking Eur. Respir. J., November 1, 2004; 24(5): 822 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Postma and H. M. Boezen Rationale for the Dutch Hypothesis: Allergy and Airway Hyperresponsiveness as Genetic Factors and Their Interaction With Environment in the Development of Asthma and COPD Chest, August 1, 2004; 126(2_suppl_1): 96S - 104S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P M A Calverley, P S Burge, S Spencer, J A Anderson, and P W Jones Bronchodilator reversibility testing in chronic obstructive pulmonary disease Thorax, August 1, 2003; 58(8): 659 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G T Verhoeven, J P J J Hegmans, P G H Mulder, J M Bogaard, H C Hoogsteden, and J-B Prins Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness Thorax, August 1, 2002; 57(8): 694 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Douma, H. A. M. Kerstjens, A. de Gooijer, S. E. Overbeek, G. H. Koeter, and D. S. Postma Initial Improvements in Lung Function and Bronchial Hyperresponsiveness Are Maintained During 5 Years of Treatment With Inhaled Beclomethasone Dipropionate and Terbutaline Chest, January 1, 2002; 121(1): 151 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The Lung Health Study Research Group Effect of Inhaled Triamcinolone on the Decline in Pulmonary Function in Chronic Obstructive Pulmonary Disease N. Engl. J. Med., December 28, 2000; 343(26): 1902 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1720 - 1745. [Full Text]
|
|
|
|
|
|
P S. BURGE;, P M VAN GRUNSVEN, and C P VAN SCHAYCK Inhaled corticosteroids in COPD Thorax, July 1, 1999; 54(7): 655a - 655. [Full Text]
|
|
|
|
|
|
P M van Grunsven, C P van Schayck, J P Derenne, H A M Kerstjens, T E J Renkema, D S Postma, T Similowski, R P Akkermans, P C M P.-d. Jong, P N R Dekhuijzen, et al. Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis Thorax, January 1, 1999; 54(1): 7 - 14. [Abstract] [Full Text]
|
|
|
|
|
|
D. S. POSTMA and H. A. M. KERSTJENS Characteristics of Airway Hyperresponsiveness in Asthma and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S187 - S192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
